(Reuters)—A federal judge on Wednesday ruled against U.S. health insurer Anthem Inc.’s proposed $54 billion merger with smaller rival Cigna Corp, derailing an unprecedented effort to consolidate the country’s health insurance industry. The U.S. Department of Justice sued in July to stop Anthem’s purchase of Cigna, a deal that would have created the largest U.S….
Articles by Natasha Yetman
U.S. House Speaker: Obamacare Replacement Law to Pass this Year
WASHINGTON (Reuters)—The U.S. House of Representatives‘ Republican leader said on Tuesday that legislation to replace former President Barack Obama’s signature healthcare law will be completed this year, trying to assuage concerns that the party is retreating from its campaign promise to dismantle Obamacare. “We are going to be done legislating with respect to healthcare and…
‘Booster Sessions’ May Help Older Adults Stick with Arthritis Exercises
NEW YORK (Reuters Health)—”Booster sessions” with a physiotherapist help older adults with osteoarthritis keep doing their exercises, a new systematic review and meta-analysis suggests. “There is strong evidence for the benefits of exercise for people with osteoarthritis or chronic low back pain. However, multiple studies have shown adherence to exercise declines over time, and the…
Disease Trends in Hispanic RA Patients in the U.S.
As the Hispanic population has grown in the U.S., very little research has examined the potentially unique clinical features of rheumatoid arthritis in these patients. A new small-scale study of Hispanic patients with RA identified trends in functional disability—showing that disease activity, pain and depression were modifiable parameters over time, with consistent, independent and additive contributions to changes in functional disability across the disease trajectory…
Similar Outcomes with Early or Late Mobilization After Rotator Cuff Repair
NEW YORK (Reuters Health)—Early or late mobilization after rotator cuff surgery appears to yield similar outcomes, according to a new meta-analysis. Dr. Bruno Fles Mazuquin from the University of Central Lancashire in the U.K., and colleagues conducted an overview of systematic reviews comparing the effectiveness of early and conservative rehabilitation after rotator cuff repair. The…
Sen. Susan Collins: Trump’s Obamacare Order ‘Confusing;’ Replacement Law Needed
WASHINGTON (Reuters)—U.S. Sen. Susan Collins (R-Me.) called President Donald Trump’s executive order against Obamacare “very confusing” on Monday, saying whatever actions the Trump administration takes, legislation will still be needed to replace the health insurance law. “We really don’t know yet what the impact (of the order) will be,” Collins told reporters, adding that it…
Trump May Not Enforce Individual Health Insurance Mandate
WASHINGTON (Reuters)—The Trump administration may no longer enforce a rule requiring individual Americans to carry health insurance or pay a penalty if they do not, a senior White House official said on Sunday Speaking on ABC’s “This Week” program, Kellyanne Conway, counselor to the president, said President Donald Trump “may stop enforcing the individual mandate.”…
Pulse Therapy & Lupus Nephritis: A 40-Year History, 1976–2016
Corticosteroids still represent the mainstay of treatment of patients with active disease. They have been used for more than 60 years, and although prolonged use is associated with organ damage, they have been shown to be lifesaving in various phases of the history of the disease. History of Use First introduced in the late 1960s…
Trump Vows ‘Insurance for Everybody’ in Replacing Obamacare
WASHINGTON (Reuters)—U.S. President-elect Donald Trump aims to replace Obamacare with a plan that would envisage “insurance for everybody,” he said in an interview with the Washington Post published on Sunday night. Trump did not give the newspaper specifics about his proposals to replace Democratic President Barack Obama’s signature health insurance law, but said the plan…
Benefits of Secukinumab in Ankylosing Spondylitis May Persist at 2 Years
NEW YORK (Reuters Health)—Secukinumab appears to improve clinical and radiographic outcomes of ankylosing spondylitis (AS) through two years of therapy, according to new results from the MEASURE 1 study. Secukinumab is a fully human monoclonal antibody against interleukin-17A, which is implicated in various pathophysiological features of spondyloarthritis. In a report online Dec. 13 in the…
- « Previous Page
- 1
- …
- 51
- 52
- 53
- 54
- 55
- …
- 97
- Next Page »